Form D · Biotechnology
Plasmology4, Inc.
Scottsdale, AZ · CIK 0001488790
Offering snapshot reported Dec 15, 2016 · SEC filing
- Reported sold
- $250K Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 13, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 15, 2016 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Apr 5, 2016 | Initial | $125,000 | No comparison | 1 | SEC filing |
| Dec 28, 2015 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Sep 2, 2015 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Jul 16, 2014 | Initial | $300,000 | No comparison | 2 | SEC filing |
| Jun 12, 2014 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Feb 11, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 19, 2012 | Amendment | Yet to sell | No comparison | 18 | SEC filing |
| Sep 14, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 26, 2012 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Jan 3, 2012 | Initial | $40,000 | No comparison | 1 | SEC filing |
| Jul 19, 2011 | Initial | $83,663 | No comparison | 2 | SEC filing |
| Jan 31, 2011 | Initial | $362,500 | No comparison | 5 | SEC filing |
| Apr 9, 2010 | Initial | $25,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-276377
Source: Form D, filed Dec 15, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David K Bane | Director, Executive |
| Barry J Bradley | Director, Executive |
| Stephen A Brigido | Director |
| Robert M Hummel | Director, Executive |
| David J Jacofsky | Director, Executive |
| Marc C Jacofsky | Executive |
| James R Lawson | Director |
| Ron Lawson | Director |
| Kevin P Mcdowell | Director |
| Kevin P Mc Dowell | Director |
| Andrew W Miller Jr. | Director |
| Ronald D Robinson | Director, Executive |
| Roy W Sanders | Director |
| Robert Taggart | Executive |
| Gregory A Watson | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8502 East Princess Drive Suite 210
Scottsdale, AZ, 85255
Scottsdale, AZ, 85255